Abnova UK and European Distributor - Antibodies, Recombinant Proteins and Assay Kits for Life Science Research

Abnova, Antibodies and Recombinant Proteins

Abnova is the world's largest monoclonal antibody manufacturer with a capacity for generating 300 mouse monoclonal antibodies and 200 rabbit polyclonal antibodies per month.

Abnova takes a genomic/proteomic approach towards antibody development, their goal being to have at least one antibody to every gene expressed in the human genome. In most cases, multiple clones are available for monoclonal antibodies. All recombinant proteins and antibodies are produced 'in house' in a state-of-the-art facility in Taiwan.

Abnova offers a unique complete monoclonal antibody and protein experience for customers that is different to traditional custom production companies and laboratories. They have an Industrial-Scale Infrastructure; maintaining a streamlined monoclonal production facility with scalable capacity for up to 500 immunizations per month, and a state-of-the-art specific pathogen free (SPF) facility, which has the breeding and holding capacity for 10,000+ mice. They also have a Wheat Germ In Vitro Protein Expression System. This is a high throughput protein production facility allowing soluble expression of conformationally correct protein, either from full-length cDNA or specific domains.



10% off All Abnova's Probes

Get 10% off Abnova's range of Probes until 30th June 2024! Contact us with promo code '202405-06_Prom' to redeem this offer.

Abnova Production Technologies

Caltag Medsystems are a UK distributor of Abnova products, bringing UK based customer service and technical support to scientists within the UK and Ireland.

Blog posts

FISH & mutaFISHâ„¢ Probes

Abnova has developed a range of FISH probes and validated mutaFISHâ„¢ (mutation-specific Fluorescence In Situ Hybridisation) probes.


VHH Antibody Applications

VHH Abs, derived from heavy-chain-only IgG Abs in the Camelidae family, present unique & exceptional potential in diverse fields of research/medicine.


miRNA In Situ Hybridisation

miRNA in situ hybridisation is a powerful technique that allows researchers to visualise and localise miRNAs within cells and tissues.


Chimeric Antigen Receptor (CAR) T Cell Therapy

Chimeric Antigen Receptor (CAR) T cell therapy is a revolutionary approach in the field of cancer immunotherapy.


Monoclonal Antibody Drugs for Cancer

Monoclonal antibody drugs have emerged as powerful tools in the fight against cancer, revolutionising treatment approaches.



  Category Title  
Show more...

No more documents to display.